Literature DB >> 16158203

[Evaluation of costs and effectiveness of an integrated outpatient training program for hypertensive patients].

Robert W Kurz1, Hans Pirker, Hermann Pötz, Waltraud Dörrscheidt, Heinz Uhlir.   

Abstract

BACKGROUND: Clinical management of hypertension needs a comprehensive therapeutic approach including both somatic and psychological aspects to ensure long-term treatment success. We have developed and evaluated an integrated outpatient training program for hypertensive patients.
METHODS: The impact of the integrated training program was evaluated in an open label prospective single-center study of 120 consecutive patients. The outpatient training program consisted of moderate physical exercise, patient education (relaxation techniques and stress management) and individual psychotherapy as indicated. Training sessions were held twice weekly during the initial six-month period. Anti-hypertensive medications were managed by the program director in close cooperation with the primary care physician. Hypertension control, medication and program costs were monitored prospectively. Evaluated parameters were measured at study enrolment (T1), upon completion of the six-month program (T2) and at follow-up at 18 +/- 5 months (T3).
RESULTS: Maximum exercise capacity increased from 85.1 +/- 1.3% at enrolment (T1) to 95.8 +/- 1.5% of the expected value at 6 months (T2) (p < 0.005). There was no change in body mass index, though a reduction in anti-hypertensive medication was observed (betablockers, -30.1%; thiazides, -20.9%; ACEI/ARB, -19.8%; calcium channel antagonist, -13.4%; alpha-blockers, -41.5%; p < 0.05; p < 0.01). Blood pressure fell from 144.6 +/- 1.8/ 88.1 +/- 0.9 at enrolment (T1) to 136.8 +/- 1.4/83.5 +/- 0.8 mm Hg at 6 month (T2) (p < 0.01). A similar decrease in systolic blood pressure at submaximal workload of 8.5 +/- 1.4 (6.6-11.2) mm Hg was observed. The daily costs for anti-hypertensive medications decreased 20.7% from EUR 0.92 to 0.73 (p < 0.01). The overall costs for the program were EUR 970 per patient. At follow-up at 18 +/- 5 months (T3), there was persistence in the reduction in medication use as well as an increase in exercise capacity. Blood pressure control had deteriorated but the values were lower than at enrolment (T1) (p = 0.1, p < 0.05).
CONCLUSION: The integrated training program represents a comprehensive and effective approach to the treatment of hypertension. The costs of the program are likely to be offset by reduced expenses for anti-hypertensive medications over time at least in part.

Entities:  

Mesh:

Year:  2005        PMID: 16158203     DOI: 10.1007/s00508-005-0402-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  6 in total

1.  [Medical therapy by training--an underestimated component of long term therapy of chronic diseases].

Authors:  Paul Haber
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  [Physical inactivity cases--one way into immobility for the elderly].

Authors:  Norbert Bachl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Functional performance in community-dwelling and institutionalized elderly women.

Authors:  Robert Csapo; Christian Gormasz; Ramon Baron
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  The prevalence of supraventricular arrhythmias with regard to the type and degree of left ventricular hypertrophy in patients with hypertensive heart disease.

Authors:  Juraj Kunisek; Luka Zaputovic; Marta Zuvic Butorac; Leon Kunisek; Ksenija Lukin-Eskinja; Rade Karlavaris; Irena Bruketa-Markic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  [Cost of disorders of the brain in Austria in the year 2004].

Authors:  Johannes Wancata; Patrick Sobocki; Heinz Katschnig
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 6.  Costing evidence for health care decision-making in Austria: A systematic review.

Authors:  Susanne Mayer; Noemi Kiss; Agata Łaszewska; Judit Simon
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.